Showing results (11-20 of 56) with videos related to
Sort By:
Pageof 6
Cancer Research|February 15, 1992
Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell linesL R Kelland, B A Murrer, G Abel, et al.Journal of Pharmaceutical and Biomedical Analysis|November 1, 1995
Determination of metabolites of a novel platinum anticancer drug JM216 in human plasma ultrafiltratesG K Poon, P Mistry, F I Raynaud, et al.Anti-Cancer Drug Design|February 25, 1998
Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum(II) (AMD473)J Holford, F Raynaud, B A Murrer, et al.Anticancer Research|July 1, 1996
Metabolism, protein binding and in vivo activity of the oral platinum drug JM216 and its biotransformation productsF I Raynaud, F E Boxall, P Goddard, et al.British Journal of Cancer|May 1, 1993
Lack of nephrotoxicity of oral ammine/amine platinum (IV) dicarboxylate complexes in rodentsM J McKeage, S E Morgan, F E Boxall, et al.Cancer Chemotherapy and Pharmacology|January 1, 1994
Preclinical toxicology and tissue platinum distribution of novel oral antitumour platinum complexes: ammine/amine platinum(IV) dicarboxylatesM J McKeage, S E Morgan, F E Boxall, et al.Cancer Research|July 15, 1992
Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylatesL R Kelland, P Mistry, G Abel, et al.The American Journal of Otology|May 1, 1997
Perspectives on a state enacted hearing screening assessment program in the newborn populationM J Abrams, M L Pensak, K BuhrerCancer Research|June 1, 1993
Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drugL R Kelland, G Abel, M J McKeage, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in miceF I Raynaud, F E Boxall, P M Goddard, et al.Pageof 6